“Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review”, IJPHRD, vol. 11, no. 7, pp. 1063–1069, Jul. 2020, doi: 10.37506/ijphrd.v11i7.10232.